Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

Adjuvants are used to maximize the potency of vaccines by enhancing immune reactions.
Components of adjuvants include pathogen-associated molecular patterns (PAMPs) and …

As the COVID-19 pandemic continues, the authorization of vaccines for emergency use has
been crucial in slowing down the rate of infection and transmission of the SARS-CoV-2 virus …

GamTBvac is a candidate tuberculosis vaccine with two fusion proteins, containing Ag85a,
ESAT6, CFP10, and a dextran-binding domain (DBD). Phase II of a double-blind …

Tuberculosis is known to be the biggest global health problem, causing the most deaths by a
single infectious agent. Vaccine-development efforts are extremely important. This paper …

Tuberculosis (TB) is now among the top ten causes of mortality worldwide being resulted in
1.7 million deaths including 0.4 million among people with HIV in 2016. The Bacille …

Tuberculosis (TB) caused by Mycobacterium tuberculosis infection is responsible for the
most deaths by a single infectious agent worldwide, with 1.6 million deaths in 2017 alone …

There is an urgent need for the development of vaccine thermostabilisation methodologies
as the maintenance of a continuous and reliable cold chain remains a major hurdle to the …

Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a deadly infectious
disease. The thin pipeline of new drugs for TB, the ineffectiveness in adults of the only …

In most cases, Mycobacterium tuberculosis (Mtb) causes life-long chronic infections, which
poses unique challenges for the immune system. Most of the current tuberculosis (TB) …